KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $202.7 million.

  • West Pharmaceutical Services' Non-Current Debt rose 4.94% to $202.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $202.7 million, marking a year-over-year increase of 4.94%. This contributed to the annual value of $202.6 million for FY2024, which is 17829.67% up from last year.
  • According to the latest figures from Q3 2025, West Pharmaceutical Services' Non-Current Debt is $202.7 million, which was up 4.94% from $202.6 million recorded in Q2 2025.
  • West Pharmaceutical Services' Non-Current Debt's 5-year high stood at $252.3 million during Q1 2021, with a 5-year trough of $72.8 million in Q4 2023.
  • For the 5-year period, West Pharmaceutical Services' Non-Current Debt averaged around $186.7 million, with its median value being $205.6 million (2023).
  • In the last 5 years, West Pharmaceutical Services' Non-Current Debt plummeted by 6477.99% in 2023 and then soared by 17829.67% in 2024.
  • Over the past 5 years, West Pharmaceutical Services' Non-Current Debt (Quarter) stood at $208.8 million in 2021, then dropped by 1.01% to $206.7 million in 2022, then crashed by 64.78% to $72.8 million in 2023, then skyrocketed by 178.3% to $202.6 million in 2024, then grew by 0.05% to $202.7 million in 2025.
  • Its Non-Current Debt was $202.7 million in Q3 2025, compared to $202.6 million in Q2 2025 and $202.6 million in Q1 2025.